| 9597314 |
Beta-lactamylalkanoic acids for treating premenstrual disorders |
Marvin J. Miller |
2017-03-21 |
|
| 8426400 |
β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
Marvin J. Miller |
2013-04-23 |
|
| 8048874 |
Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
Marvin J. Miller |
2011-11-01 |
|
| 7998991 |
Neurotherapeutic treatment for sexual dysfunction |
— |
2011-08-16 |
|
| 7842683 |
Neurotherapeutic compositions and method |
— |
2010-11-30 |
|
| 7833998 |
Oral neurotherapeutic cephalosporin sulfoxide and sulfone-containing compositions |
Michael O. Chaney |
2010-11-16 |
|
| 7268125 |
β-lactamyl vasopressin V1a antagonists |
Robert F. Bruns, Jr., Christophe Guillon, Ned D. Heindel, Marvin J. Miller |
2007-09-11 |
|
| 7166626 |
Therapeutic treatment for sexual dysfunction |
— |
2007-01-23 |
|
| 7119083 |
β-Lactamyl vasopressin V1a Antagonists |
Robert F. Bruns, Jr., Christophe Guillon, Ned D. Heindel, Marvin J. Miller |
2006-10-10 |
|
| 6627625 |
Treatment of behavioral disorders with &bgr;-lactam compounds |
— |
2003-09-30 |
|
| 6610680 |
Non-peptidyl vasopressin V1A antagonists |
Robert F. Bruns, Jr., Robin D G Cooper, Bruce A. Dressman, David C. Hunden, Stephen W. Kaldor +3 more |
2003-08-26 |
$115,876,000 |
| 6610681 |
Neurotherapeutic clavulanate composition and method |
— |
2003-08-26 |
|
| 6521611 |
Non-peptidyl vasopressin V1a antagonists |
Robert F. Bruns, Jr., Robin D G Cooper, Bruce A. Dressman, David C. Hunden, Stephen W. Kaldor +3 more |
2003-02-18 |
$148,484,000 |
| 6489319 |
Neurotherapeutic use of carboxypeptidase inhibitors |
Michael O. Chaney |
2002-12-03 |
|
| 6426342 |
Use of &bgr;-lactamase inhibitors as neuroprotectants |
— |
2002-07-30 |
|
| 6204260 |
Non-peptidyl vasopressin V1a antagonists |
Robert F. Bruns, Jr., Robin D G Cooper, Bruce A. Dressman, David C. Hunden, Stephen W. Kaldor +3 more |
2001-03-20 |
$1,153,187,000 |
| 5759865 |
Combinatorial process for synthesizing azetidinone analogs |
Robert F. Bruns, Jr., Michael O. Chaney, Robin D G Cooper, David C. Hunden, Jeffrey J Skelton |
1998-06-02 |
$99,031,000 |
| 5747524 |
Cannabinoid receptor antagonists |
George J. Cullinan, Kennan J. Fahey |
1998-05-05 |
$134,602,000 |
| 5665358 |
Antibody drug-conjugates |
Russell L. Barton, Deborah L. Guttman-Carlisle |
1997-09-09 |
$51,213,000 |
| 5643573 |
Antibody-drug conjugates |
Russell L. Barton, Deborah L. Guttman-Carlisle |
1997-07-01 |
$32,837,000 |
| 5596106 |
Cannabinoid receptor antagonists |
George J. Cullinan, Kennan J. Fahey |
1997-01-21 |
$74,830,000 |
| 5556623 |
Antibody-drug conjugates |
Russell L. Barton, Deborah L. Guttman-Carlisle |
1996-09-17 |
$60,282,000 |
| 5272253 |
Cluster conjugates of drugs with antibodies |
Robin Offord, Keith Rose, William Leonard Scott |
1993-12-21 |
$37,421,000 |
| 4994558 |
Immunoglobulin conjugates |
Henry K. Armour, G. Davon Kennedy, William Leonard Scott |
1991-02-19 |
$57,048,000 |
| 4814438 |
Immunoglobulin conjugates of 2',2'-difluronucleosides |
Henry K. Armour, G. Davon Kennedy, William Leonard Scott |
1989-03-21 |
$51,389,000 |
